Technical Analysis for VCEL - Vericel Corporation

Grade Last Price % Change Price Change
grade D 15.5 2.11% 0.32
VCEL closed up 2.11 percent on Thursday, October 17, 2019, on 51 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical VCEL trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
New Uptrend Bullish 0.00%
Gapped Up Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Doji - Bearish? Reversal 2.11%
Crossed Above 20 DMA Bullish 2.31%
MACD Bullish Signal Line Cross Bullish 7.27%
Up 3 Days in a Row Strength 7.27%
Oversold Stochastic Weakness 9.23%
Calm After Storm Range Contraction 10.87%

Older signals for VCEL ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Vericel Corporation, a commercial-stage biopharmaceutical company, focuses on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. It markets two autologous cell therapy products in the United States, including Carticel (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee; and Epicel (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area. The company is also developing MACI, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee; and ixmyelocel-T, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy. The company, formerly known as Aastrom Biosciences, Inc., was founded in 1989 and is headquartered in Cambridge, Massachusetts.
Medicine Biotechnology Biopharmaceutical Medical Specialties Stem Cells Cell Therapy Burns Knee Severe Diseases
Is VCEL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.0
52 Week Low 10.51
Average Volume 465,471
200-Day Moving Average 17.3903
50-Day Moving Average 15.8469
20-Day Moving Average 14.7708
10-Day Moving Average 14.48
Average True Range 0.6255
ADX 27.74
+DI 21.6018
-DI 20.7967
Chandelier Exit (Long, 3 ATRs ) 14.4435
Chandelier Exit (Short, 3 ATRs ) 15.2765
Upper Bollinger Band 16.3433
Lower Bollinger Band 13.1983
Percent B (%b) 0.73
BandWidth 21.292009
MACD Line -0.3153
MACD Signal Line -0.5231
MACD Histogram 0.2078
Fundamentals Value
Market Cap 508.76 Million
Num Shares 32.8 Million
EPS -1.04
Price-to-Earnings (P/E) Ratio -14.90
Price-to-Sales 2.75
Price-to-Book 10.56
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.01
Resistance 3 (R3) 15.98 15.79 15.93
Resistance 2 (R2) 15.79 15.66 15.80 15.90
Resistance 1 (R1) 15.64 15.58 15.72 15.67 15.87
Pivot Point 15.45 15.45 15.48 15.46 15.45
Support 1 (S1) 15.30 15.32 15.38 15.33 15.13
Support 2 (S2) 15.11 15.24 15.12 15.10
Support 3 (S3) 14.96 15.11 15.08
Support 4 (S4) 14.99